Literature DB >> 20980738

The effect of PACAP38 on MyD88-mediated signal transduction in ischemia-/hypoxia-induced acute kidney injury.

Min Li1, Altaf-M Khan, Jerome L Maderdrut, Eric E Simon, Vecihi Batuman.   

Abstract

BACKGROUND/AIMS: toll-like receptor 4 (TLR4) and its adaptor protein MyD88 play an important role in ischemia/reperfusion (I/R) injury in the kidney, and pituitary adenylate cyclase-activating polypeptide (PACAP) could ameliorate renal I/R injury.
METHODS: primary cultures of proximal tubule epithelial cells (PTEC) were prepared from wild-type and MyD88(-/-) mice, and subjected to hypoxia in vitro. Acute kidney injury (AKI) was induced by I/R in vivo in wild-type mice only.
RESULTS: hypoxia resulted in significant increases in cytokine production and apoptosis/necrosis in wild-type PTEC, but these responses were markedly blunted in MyD88(-/-) PTEC. Treatment with PACAP38 before or after hypoxia further suppressed the hypoxia-induced cytokine responses and apoptosis in both MyD88(+/+) and MyD88(-/-) PTEC cultures. PACAP38 significantly inhibited TLR4/MyD88/TRAF6 as well as TRIF and IRF3 expression in mouse kidney and PTEC, and inhibited the secretion and mRNA expression of cytokines in kidneys from mice after I/R, paralleling the cytokine responses in vitro. Moreover, treatment with PACAP38 protected mice from renal failure, histological damage, neutrophil influx and tubule cell apoptosis after I/R.
CONCLUSION: our data reveal that the TLR4-mediated cytokine responses to hypoxia are primarily dependent on MyD88 signaling and highlight the pivotal role of MyD88-dependent mechanisms in the coordination of the innate immune responses to ischemic/hypoxic acute renal tubular injury. The renoprotective effect of PACAP in AKI involves both MyD88-dependent and -independent pathways. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980738     DOI: 10.1159/000321491

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  17 in total

1.  Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway.

Authors:  Haofeng Ji; Yu Zhang; Xiu-da Shen; Feng Gao; Cynthia Y Huang; Catalina Abad; Ronald W Busuttil; James A Waschek; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2013-01-18       Impact factor: 17.425

2.  Protective Effects and Mechanisms of Shenhua Tablet () on Toll-Like Receptors in Rat Model of Renal Ischemia-Reperfusion Injury.

Authors:  Qing-Ping Li; Ri-Bao Wei; Xi Yang; Xiao-Yong Zheng; Ting-Yu Su; Meng-Jie Huang; Zhong Yin; Xiang-Mei Chen
Journal:  Chin J Integr Med       Date:  2017-05-03       Impact factor: 1.978

3.  14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury.

Authors:  Haibin Tian; Yan Lu; Shraddha P Shah; Quansheng Wang; Song Hong
Journal:  Stem Cells Dev       Date:  2011-10-03       Impact factor: 3.272

Review 4.  Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury.

Authors:  Hailin Zhao; Jessica Santiváñez Perez; Kaizhi Lu; Andrew J T George; Daqing Ma
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-12

5.  Transgenerational effects of binge drinking in a primate model: implications for human health.

Authors:  Catherine A VandeVoort; Kristin N Grimsrud; Uros Midic; Namdori Mtango; Keith E Latham
Journal:  Fertil Steril       Date:  2014-12-06       Impact factor: 7.329

6.  Regulatory effects of AT₁R-TRAF6-MAPKs signaling on proliferation of intermittent hypoxia-induced human umbilical vein endothelial cells.

Authors:  Jin Shang; Xue-Ling Guo; Yan Deng; Xiao Yuan; Hui-Guo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31

7.  Free light chains injure proximal tubule cells through the STAT1/HMGB1/TLR axis.

Authors:  Rohit Upadhyay; Wei-Zhong Ying; Zannatul Nasrin; Hana Safah; Edgar A Jaimes; Wenguang Feng; Paul W Sanders; Vecihi Batuman
Journal:  JCI Insight       Date:  2020-07-23

8.  Pituitary adenylate cyclase-activating polypeptide prevents contrast-induced nephropathy in a novel mouse model.

Authors:  Altaf-M Khan; Jerome L Maderdrut; Min Li; Herman L Toliver; David H Coy; Eric E Simon; Vecihi Batuman
Journal:  Physiol Rep       Date:  2013-11-19

9.  Pituitary adenylate cyclase-activating polypeptide protects glomerular podocytes from inflammatory injuries.

Authors:  Kenichi Sakamoto; Kyoko Kuno; Minoru Takemoto; Peng He; Takahiro Ishikawa; Shunichiro Onishi; Ryoichi Ishibashi; Emiko Okabe; Mayumi Shoji; Akiko Hattori; Masaya Yamaga; Kazuki Kobayashi; Harukiyo Kawamura; Hirotake Tokuyama; Yoshiro Maezawa; Koutaro Yokote
Journal:  J Diabetes Res       Date:  2015-03-02       Impact factor: 4.011

10.  Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro.

Authors:  Li-Min Zhang; Jian-Hua Liu; Cheng-Biao Xue; Ming-Qiang Li; Shuai Xing; Xue Zhang; Wen-Tao He; Feng-Chao Jiang; Xia Lu; Ping Zhou
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.